Recurrences after intensity modulated radiotherapy for head and neck squamous cell carcinoma more likely to originate from regions with high baseline [18F]-FDG uptake

Radiotherapy and Oncology

Volumn 111, Issue 3, 2014, Pages 360-365

  Due, Anne K ^a   Vogelius, Ivan R ^a   Aznar, Marianne C ^a,b   Bentzen, Søren M ^a,c,d   Berthelsen, Anne K ^a   Korreman, Stine S ^b,e   Loft, Annika ^a   Kristensen, Claus A ^a   Specht, Lena ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^e ROSKILDE UNIVERSITY   (Denmark)

Author keywords

FDG PET; Head and neck cancer; Pattern of failure; Radiotherapy; Recurrence

Indexed keywords

CISPLATIN; FLUORODEOXYGLUCOSE F 18; NIMORAZOLE;

ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CHEMORADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DENSITY; DRUG UPTAKE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN TISSUE; HYPOPHARYNX CANCER; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION ABSORPTION; RADIATION DOSE DISTRIBUTION; SALVAGE THERAPY; TREATMENT FAILURE; TREATMENT PLANNING; TREATMENT RESPONSE; LARYNX CARCINOMA; MOUTH CANCER; MOUTH CARCINOMA; PHARYNX CARCINOMA; RADIATION DOSE;

FDG-PET; HEAD AND NECK CANCER; PATTERN OF FAILURE; RADIOTHERAPY; RECURRENCE;

CARCINOMA, SQUAMOUS CELL; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; MULTIMODAL IMAGING; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84905230612     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2014.06.001     Document Type: Article

References (17)

1. S.M. Bentzen Theragnostic imaging for radiation oncology: dose-painting by numbers Lancet Oncol 6 2005 112 117 (Pubitemid 40197705)
2. A. Brahme Biologically optimized 3-dimensional in vivo predictive assay-based radiation therapy using positron emission tomography-computerized tomography imaging Acta Oncol 42 2003 123 136 (Pubitemid 36570777)
3. C.C. Ling, J. Humm, and S. Larson et al. Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality Int J Radiat Oncol Biol Phys. 47 2000 551 560 (Pubitemid 30317470)
4. A. Brahme, and A.K. Agren Optimal dose distribution for eradication of heterogeneous tumours Acta Oncol 26 1987 377 385 (Pubitemid 18044580)
5. A. Sovik, E. Malinen, and O.S. Bruland et al. Optimization of tumour control probability in hypoxic tumours by radiation dose redistribution: a modelling study Phys Med Biol 52 2007 499 513 (Pubitemid 46646466)
6. I.R. Vogelius, K. Håkansson, and A.K. Due et al. Failure-probability driven dose painting Med Phys 40 2013 081717
7. S.M. Bentzen, and V. Gregoire Molecular imaging-based dose painting: a novel paradigm for radiation therapy prescription Semin Radiat Oncol 21 2011 101 110
8. H. Jadvar, A. Alavi, and S.S. Gambhir 18F-FDG uptake in lung, breast, and colon cancers: molecular biology correlates and disease characterization J Nucl Med 50 2009 1820 1827
9. A.K. Due, I.R. Vogelius, and M.C. Aznar et al. Methods for estimating the site of origin of locoregional recurrence in head and neck squamous cell carcinoma Strahlenther Onkol 188 2012 671 676
10. S.M. Bentzen, D.I. Rosenthal, and E.A. Weymuller et al. Increasing toxicity in nonoperative head and neck cancer treatment: investigations and interventions Int J Rad Oncol Biol Phys 69 2007 S79 S82
11. A. Trotti Toxicity in head and neck cancer: a review of trends and issues Int J Radiat Oncol Biol Phys 47 2000 1 12 (Pubitemid 30179674)
12. S.A. Raktoe, H. Dehnad, and C.P. Raaijmakers et al. Origin of tumor recurrence after intensity modulated radiation therapy for oropharyngeal squamous cell carcinoma Int J Radiat Oncol Biol Phys 2012
13. W.M. Mendenhall, R.J. Amdur, and J.R. Palta Intensity-modulated radiotherapy in the standard management of head and neck cancer: promises and pitfalls J Clin Oncol 24 2006 2618 2623 (Pubitemid 46622082)
14. D.E. Soto, M.L. Kessler, and M. Piert et al. Correlation between pretreatment FDG-PET biological target volume and anatomical location of failure after radiation therapy for head and neck cancers Radiother Oncol 89 2008 13 18
15. P. Dirix, V. Vandecaveye, and F. De Keyzer et al. Dose painting in radiotherapy for head and neck squamous cell carcinoma: value of repeated functional imaging with (18)F-FDG PET, (18)F-fluoromisonidazole PET, diffusion-weighted MRI, and dynamic contrast-enhanced MRI J Nucl Med 50 2009 1020 1027
16. I. Madani, W. Duthoy, and C. Derie et al. Positron emission tomography-guided, focal-dose escalation using intensity-modulated radiotherapy for head and neck cancer Int J Radiat Oncol Biol Phys 68 2007 126 135 (Pubitemid 46589860)
17. I. Madani, F. Duprez, and T. Boterberg et al. Maximum tolerated dose in a phase I trial on adaptive dose painting by numbers for head and neck cancer Radiother Oncol 101 2011 351 355